Acute kidney injury: risk factors and management challenges in developing countries.
Daniela Ponce, Andre Balbi
https://pubmed.ncbi.nlm.nih.gov/27578995/Actively Recruiting
Led by University of Alabama at Birmingham · Updated on 2026-03-12
1000
Participants Needed
15
Research Sites
13 weeks
Total Duration
Researchers are conducting an international, multicenter observational study to understand acute kidney injury requiring renal replacement therapy AKI-RRT in Latin American countries. The study focuses on the epidemiology, outcomes, and care processes for patients with AKI-RRT, comparing variations across different countries and examining factors such as demographics, clinical profiles, and socioeconomic status that may influence patient outcomes. The aim is to establish a comprehensive database to support clinical research and improve understanding of AKI-RRT in this region. The study observes critically ill adult patients admitted to intensive care units ICUs who are undergoing any form of renal replacement therapy. It collects detailed clinical, laboratory, treatment, and outcome data without assigning treatments, as it is observational. Patients are followed from enrollment through hospital discharge or up to 90 days, including ICU stay and 90-day post-ICU follow-up to track mortality, renal recovery, and complications related to renal replacement therapy. Participants involvement includes monitoring during ICU and hospital stays with data collected on mortality rates, length of stay, renal function recovery, dependence on renal replacement therapy, and complications such as infections or anticoagulation issues. The primary outcome measured is in-hospital mortality, with secondary outcomes covering ICU mortality, 90-day mortality, length of stay, recovery, and procedural complications. This study spans from enrollment until 90 days after ICU admission, providing extensive observational data on AKI-RRT in Latin America.
CONDITIONS
Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America
J
Javier A Neyra, MD, MSCS
P
Patricia J Busta Flores
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Alabama at Birmingham
Lead Sponsor
Vantive Health LLC
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 90 days or until hospital discharge
Participants who undergo routine care for acute kidney injury requiring renal replacement therapy are observed during their ICU and hospital stay.
Daily assessments during ICU and hospital stay
Duration - Up to 90 days post-ICU admission
Participants are followed up for outcomes up to 90 days post-ICU admission to assess mortality and renal function recovery.
Follow-up visits or contacts as scheduled up to 90 days
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Daniela Ponce, Andre Balbi
https://pubmed.ncbi.nlm.nih.gov/27578995/Marina Wainstein, Yannick Nlandu, Andrea Viecelli...
https://pubmed.ncbi.nlm.nih.gov/39405323/Paweena Susantitaphong, Dinna N Cruz, Jorge Cerda...
https://pubmed.ncbi.nlm.nih.gov/23744003/Aminu K Bello, Mark McIsaac, Ikechi G Okpechi...
https://pubmed.ncbi.nlm.nih.gov/33981472/Raúl Lombardi, Guillermo Rosa-Diez, Alejandro Ferreiro...
https://pubmed.ncbi.nlm.nih.gov/24744281/Aqeeb Ur Rehman, Stefania Renzi, David Andres Ballesteros Castro...
https://pubmed.ncbi.nlm.nih.gov/40814609/Ravindra L Mehta, Emmanuel A Burdmann, Jorge Cerdá...
https://pubmed.ncbi.nlm.nih.gov/27086173/Aqeeb Ur Rehman, Natalia Nombera-Aznaran, Stefania Renzi...
https://pubmed.ncbi.nlm.nih.gov/42342404/University of Alabama at Birmingham
Lead Sponsor
Vantive Health LLC
Collaborating Sponsor